These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30167036)

  • 1. Factors associated with interruption of tuberculosis treatment among patients in Nandi County, Kenya 2015.
    Wanyonyi AW; Wanjala PM; Githuku J; Oyugi E; Kutima H
    Pan Afr Med J; 2017; 28(Suppl 1):11. PubMed ID: 30167036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with interruption of treatment among Pulmonary Tuberculosis patients in Plateau State, Nigeria. 2011.
    Ibrahim LM; Hadejia IS; Nguku P; Dankoli R; Waziri NE; Akhimien MO; Ogiri S; Oyemakinde A; Dalhatu I; Nwanyanwu O; Nsubuga P
    Pan Afr Med J; 2014; 17():78. PubMed ID: 24711884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of tuberculosis treatment interruption among patients in Vihiga County, Kenya.
    Wekunda PW; Aduda DSO; Guyah B
    PLoS One; 2021; 16(12):e0260669. PubMed ID: 34855844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing knowledge on completion of treatment among TB patients under directly observed treatment strategy, in selected health facilities in Embu County, Kenya.
    Ndwiga JM; Kikuvi G; Omolo JO
    Pan Afr Med J; 2016; 25():234. PubMed ID: 28293350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial.
    Browne SH; Umlauf A; Tucker AJ; Low J; Moser K; Gonzalez Garcia J; Peloquin CA; Blaschke T; Vaida F; Benson CA
    PLoS Med; 2019 Oct; 16(10):e1002891. PubMed ID: 31584944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study.
    Muture BN; Keraka MN; Kimuu PK; Kabiru EW; Ombeka VO; Oguya F
    BMC Public Health; 2011 Sep; 11():696. PubMed ID: 21906291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Survival Analysis to Identify Risk Factors for Treatment Interruption among New and Retreatment Tuberculosis Patients in Kenya.
    Masini EO; Mansour O; Speer CE; Addona V; Hanson CL; Sitienei JK; Kipruto HK; Githiomi MM; Mungai BN
    PLoS One; 2016; 11(10):e0164172. PubMed ID: 27706230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia.
    Mekonnen HS; Azagew AW
    BMC Res Notes; 2018 Oct; 11(1):691. PubMed ID: 30285907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with non-adherence during tuberculosis treatment among patients treated with DOTS strategy in Jayapura, Papua Province, Indonesia.
    Ruru Y; Matasik M; Oktavian A; Senyorita R; Mirino Y; Tarigan LH; van der Werf MJ; Tiemersma E; Alisjahbana B
    Glob Health Action; 2018; 11(1):1510592. PubMed ID: 30394200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia: A Five-Year Retrospective Study.
    Gebrezgabiher G; Romha G; Ejeta E; Asebe G; Zemene E; Ameni G
    PLoS One; 2016; 11(2):e0150560. PubMed ID: 26918458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis treatment outcomes and interruption among patients assessing DOTS regimen in a tertiary hospital in semi-urban area of south-western Nigeria.
    Omotosho BA; Adebayo AM; Adeniyi BO; Ayodeji OO; Ilesanmi OS; Kareem AO; Akitikori OT; Erhabor GE
    Niger J Med; 2014; 23(1):51-6. PubMed ID: 24946455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya.
    Ogwang MO; Imbuga M; Ngugi C; Mutharia L; Magoma G; Diero L
    BMC Infect Dis; 2021 Nov; 21(1):1175. PubMed ID: 34809602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and factors associated for anti-tuberculosis treatment non-adherence among pulmonary tuberculosis patients in public health care facilities in South Ethiopia: a cross-sectional study.
    Woimo TT; Yimer WK; Bati T; Gesesew HA
    BMC Public Health; 2017 Mar; 17(1):269. PubMed ID: 28320351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing TB treatment interruption and treatment outcomes among patients in Kiambu County, 2016-2019.
    Kimani E; Muhula S; Kiptai T; Orwa J; Odero T; Gachuno O
    PLoS One; 2021; 16(4):e0248820. PubMed ID: 33822794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient attitudes towards community-based tuberculosis DOT and adherence to treatment in an urban setting; Kampala, Uganda.
    Hassard S; Ronald A; Angella K
    Pan Afr Med J; 2017; 27():1. PubMed ID: 28748003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the unsuccessful TB treatment outcomes in the northern regions of Namibia: a mixed methods study.
    Amkongo M; Mitonga HK; Alfeus A; Shipingana LNN; Keendjele T; Eelu H; Nashihanga T
    BMC Infect Dis; 2023 May; 23(1):342. PubMed ID: 37217848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia.
    Tesfahuneygn G; Medhin G; Legesse M
    BMC Res Notes; 2015 Sep; 8():503. PubMed ID: 26420164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with compliance among tuberculosis patients in Thailand.
    Lertmaharit S; Kamol-Ratankul P; Sawert H; Jittimanee S; Wangmanee S
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S149-56. PubMed ID: 16623020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India.
    Negandhi H; Tiwari R; Sharma A; Nair R; Zodpey S; Reddy Allam R; Oruganti G
    Glob Health Action; 2017; 10(1):1290315. PubMed ID: 28485693
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.